| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3806547 | F | Antibacterial activity against Staphylococcus aureus NRS70 after 16 to 20 hrs by two-fold serial dilution method | Staphylococcus aureus | 1 | ALA3804827 | organism-based format | Scientific Literature | |
| 2. | ALA3819906 | F | Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 incubated for 16 to 20 hrs by microdilution method | Staphylococcus aureus | 79 | ALA3817745 | organism-based format | Scientific Literature | |
| 3. | ALA3820012 | A | Protein binding in human plasma at 10 uM after 6 hrs by UPLC based equillibrium dialysis method | Homo sapiens | 1 | ALA3817745 | cell-free format | Scientific Literature | |
| 4. | ALA3820013 | A | AUC (0 to last) in ICR mouse peritonitis model infected with methicillin resistant Staphylococcus aureus ATCC 27660 at 10 mg/kg, iv administered as single dose measured up to 8 hrs by UPLC analysis | Mus musculus | 7 | ALA3817745 | organism-based format | Scientific Literature | |
| 5. | ALA3820016 | A | Clearance in ICR mouse peritonitis model infected with methicillin resistant Staphylococcus aureus ATCC 27660 at 10 mg/kg, iv administered as single dose measured up to 8 hrs by UPLC analysis | Mus musculus | 7 | ALA3817745 | organism-based format | Scientific Literature | |
| 6. | ALA3820019 | A | Cytotoxicity against human HepG2 cells incubated for 16 hrs by XTT assay | Homo sapiens | 12 | ALA3817745 | cell-based format | Scientific Literature | |
| 7. | ALA3820020 | F | Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 27660 infected in iv dosed ICR mouse model of peritonitis assessed as mouse survival administered at 30 mins and 4.5 hrs post infection measured for 48 hrs | Staphylococcus aureus | 1 | ALA3817745 | organism-based format | Scientific Literature | |
| 8. | ALA3820021 | A | Hemolytic activity against human RBC at 64 ug/ml relative to control | Homo sapiens | 12 | ALA3817745 | cell-based format | Scientific Literature | |
| 9. | ALA3820024 | F | Antibacterial activity against mecA-positive methicillin/oxacillin/tetracycline-resistant Staphylococcus aureus ATCC 27660 incubated for 16 to 20 hrs by microdilution method | Staphylococcus aureus | 9 | ALA3817745 | organism-based format | Scientific Literature | |
| 10. | ALA3820025 | F | Antibacterial activity against mecA-positive multidrug resistant Staphylococcus aureus COL NRS100 incubated for 16 to 20 hrs by microdilution method | Staphylococcus aureus | 9 | ALA3817745 | organism-based format | Scientific Literature | |
| 11. | ALA3820026 | F | Antibacterial activity against mecA-positive multidrug resistant Staphylococcus aureus NRS119 incubated for 16 to 20 hrs by microdilution method | Staphylococcus aureus | 9 | ALA3817745 | organism-based format | Scientific Literature | |
| 12. | ALA3820027 | F | Antibacterial activity against mecA-positive multidrug resistant Staphylococcus aureus NRS120 incubated for 16 to 20 hrs by microdilution method | Staphylococcus aureus | 9 | ALA3817745 | organism-based format | Scientific Literature | |
| 13. | ALA3820028 | F | Antibacterial activity against vancomycin/methicillin-resistant Staphylococcus aureus VRS1 clinical isolate incubated for 16 to 20 hrs by microdilution method | Staphylococcus aureus | 9 | ALA3817745 | organism-based format | Scientific Literature | |
| 14. | ALA3820029 | F | Antibacterial activity against vancomycin/methicillin-resistant Staphylococcus aureus VRS2 clinical isolate incubated for 16 to 20 hrs by microdilution method | Staphylococcus aureus | 9 | ALA3817745 | organism-based format | Scientific Literature | |
| 15. | ALA3820030 | F | Antibacterial activity against Staphylococcus epidermidis ATCC 35547 incubated for 16 to 20 hrs by microdilution method | Staphylococcus epidermidis | 9 | ALA3817745 | organism-based format | Scientific Literature | |
| 16. | ALA3820031 | F | Antibacterial activity against Staphylococcus haemolyticus ATCC 29970 incubated for 16 to 20 hrs by microdilution method | Staphylococcus haemolyticus | 9 | ALA3817745 | organism-based format | Scientific Literature | |
| 17. | ALA3820032 | F | Antibacterial activity against Streptococcus oralis ATCC 9811 incubated for 16 to 20 hrs by microdilution method | Streptococcus oralis | 9 | ALA3817745 | organism-based format | Scientific Literature | |
| 18. | ALA3820033 | F | Antibacterial activity against Streptococcus pyogenes ATCC 49399 incubated for 16 to 20 hrs by microdilution method | Streptococcus pyogenes | 9 | ALA3817745 | organism-based format | Scientific Literature | |
| 19. | ALA3820034 | F | Antibacterial activity against Bacillus cereus ATCC 13061 incubated for 16 to 20 hrs by microdilution method | Bacillus cereus | 9 | ALA3817745 | organism-based format | Scientific Literature | |
| 20. | ALA3820035 | F | Antibacterial activity against Bacillus licheniformis ATCC 12759 incubated for 16 to 20 hrs by microdilution method | Bacillus licheniformis | 9 | ALA3817745 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!